Moreover, approximately 75% of Ma et al.’s cohort [31] comprised patients with sepsis or septic shock, whereas only 27% of our study population met sepsis criteria, reflecting differences in underlying disease mechanisms that may influence RIPK3 activation. This evidence concerns the gene RIPK3 and Sepsis.